Randomized phase II study of gemcitabine (G), cisplatin (C) with or without veliparib (V) (arms A, B) and a phase II single-arm study of single-agent veliparib (arm C) in patients with BRCA or PALB2-mutated pancreas adenocarcinoma (PC)

Authors
Category Primary study
JournalJOURNAL OF CLINICAL ONCOLOGY
Year 2013
This article has no abstract
Epistemonikos ID: a4c66ab3d179ad00aea08473601d5af069e258be
First added on: Feb 05, 2025